Amy McBride Wendell - 08 May 2026 Form 4 Insider Report for Axogen, Inc. (AXGN)

Reporting relationship: Director
Issuer ticker: AXGN
Reported as of: 08 May 2026
Net transaction value: -$70,162
SEC form: 4
Accepted by SEC: 12 May 2026, 16:06:30 UTC
Prior SEC filing: 07 May 2026
Next SEC filing: 18 May 2026
Source filing: View source filing
Reporting owner signature: /s/ Marc Began, as attorney-in-fact for Amy McBride-Wendell

Key filing fact

Amy McBride Wendell filed Form 4 for Axogen, Inc. (AXGN) on 12 May 2026.

Key facts

This page summarizes Amy McBride Wendell's Form 4 filing for Axogen, Inc. (AXGN).
3 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 12 May 2026, 16:06.

Change

Previous filing in this sequence was filed on 07 May 2026.
Current net transaction value: -$70,162.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001400568 Primary reporting owner

Wendell Amy McBride

Relationship: Director
Address: C/O AXOGEN, INC. 13631 PROGRESS BLVD., SUITE 400, ALACHUA
Signature: /s/ Marc Began, as attorney-in-fact for Amy McBride-Wendell
Signature date: 12 May 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

AXGN transaction

Common Stock

Options Exercise

Transaction value
Shares: +1,647
Change %: +1.8%
Price: $14.85^*
Shares after: 95,473
Date: 08 May 2026
Ownership: Direct

AXGN transaction

Common Stock

Sale

Transaction value: $70,162
Shares: -1,647
Change %: -1.7%
Price: $42.60
Shares after: 93,826
Date: 08 May 2026
Ownership: Direct
Footnotes: F1

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

AXGN transaction Derivative

Employee Stock Option (right to purchase)

Options Exercise

Transaction value
Shares: -1,647
Change %: -11%
Price: $0.000000^*
Shares after: 13,353
Date: 08 May 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 1,647
Exercise price: $14.85
Footnotes: F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

The reported price in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $42.50 to $42.62 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

Footnote F2

All shares of Axogen, Inc. common stock underlying the board of director's stock option were fully vested on May 31, 2018.